6th International Conference on
Nanomedicine and Nanotechnology

Mirela Olympia Fagarasan Palmer works in academia as an internationally recognized neuropharmacology and neuroimmunology researcher. She published more than 500 scientific reports in the field of neuropsychopharmacology and signal transduction. She is leading a laboratory interested in understanding the fundamental neurobiological mechanisms of neuropsychiatric disorders to contribute at development of new pharmacological treatments. Uses genetic, neuroendocrine and neurochemical methods. She recognized the role of the immune system in modulating neuropsychiatric diseases and we are developing in vitro cellular models and in vivo animal models to study the neuro-immune interactions under normal and disease states. She has successfully combined research, teaching, administration and clinical care and continue to work on advancing and understanding the cause of serious mental illness.

Neuropsychopharmacology, Aging,Alzheimer's Disease, Neurodegeration, Regeneration, Signal Transduction.

Paul Stannard has worked internationally in the US, Europe, Middle East and Asia and spoke at Davos 2019 about the next industrial revolution (Industry 4.0) and the impact on Smart Cities and how Nanoscale technologies will change the world in almost every area of life including sustainable healthcare, energy, food production, transport, infrastructure, AI and telecoms and communications.Chairman of The World Nano Foundation for the commercialisation of nanotechnology. Chairman of Trustees for World Science Aid and Chairman and Founder of Nano Media Group who are launching an investment funding programme where Nanotechnology research and IP can be potentially used as a tangible asset for funding and investment. He is also Chairman of Enabling Tech Capital based in London. He is a passionate advocate for Nanomedicine, Nano materials as well as other Nano enabled technologies which create significant global value and impact as well as sustainability for everyone.

Impact Investment Future for Nanotechnology

Ph.D. Rangel-Vázquez is a researcher at PCC. She have served as a reviewer for several journals: Journal of Applied Polymer Science, Materials Letters, Carbohydrate Polymers, Journal Polymer Engineering & Science, Thermochimica Acta, Journal of Molecular Structure, Journal of Surface and Coatings Technology, Academic Journal of Agricultural Research, World Journal of Engineering and Physical Sciences (WJEPS), Annual Research & Review in Biology, Journal of Applied Physical Science International, Global Conference on Polymer and Composite Materials 2015 and International Journal of Nanomedicine. She have worked in the Organizing of International congress such as: 2016 Spring World Congress on Engineering and Technologies (SCET 2016) in the topic: 2016 Spring International Conference on Materials Sciences and Technologies (MST-S-China); 2nd Conference International of Surface and Interface on Materials (Thailand, 2016); The 2nd Int'l Conference on Biomaterials and Applications (ICBA 2017), Thailand; The 3rd Int'l Conference on Surface and Interface of Materials (SIM 2017), China. The 3rd Int'l Conference on Advanced Composite Materials (ACM 2017), Thailand. She is on the Editorial Board of several journals including Journal of Pharmaceutics & Drug Development, Material Science and Engineering with Advanced Research, Journal of Nanomedicine Research, Nanomedicine Research Journal, Chemistry Journal, BAOJ Pharmaceutical Sciences (Bioaccent), Independent Journal of Managment & Production (Brazil) and Global Journal of Nanomedicine. She is an Editor in Chief of BAOJ Pharmaceutical Sciences and the Journal of Pharmaceutics & Drug Development, respectively.

Nanotechnology applied to controlled drug delivery systems. In particular, skin and brain cancer, diabetes mellitus, antifungical, Design and preparation of oral solid (tablets and capsules) dosage forms, Analysis of drugs in pure forms, formulations and biological matrices, Bioadhesive drug delivery systems, especially hydrogels, polymers, biopolymers and IPNs, respectively.

Dr Abbas Amini is an assistant professor at the Australian College of ACK and Western Sydney University, and the member of graduate supervisory board. After obtaining PhD, he conducted research with other Australian universities, as a postdoctoral research fellow at Monash and Deakin Universities, and as a senior research fellow at the University of Melbourne. His fine outcomes have been presented in high impact factor journals, e.g., Nature publication group, and a recent published book in 2016. Abbas is the editor of ten reputed journals, and the committee member of 20 international conferences.

Advanced materials, Nanobiotech

Ziyad S. Haidar is an Associate Professor of Biomaterials and Tissue Engineering and the Scientific Director of the Centro de Investigación en Biología y Regeneración Oral (CIBRO), Centro de Investigación Biomédica (CIB), Facultad de Odontología, Universidad de los Andes in Santiago de Chile. Concurrently, Prof. Dr. Haidar is the Founder and Head of the Biomaterials, Pharmaceutical Delivery and Cranio-Maxillo-Facial Tissue Engineering Laboratory (BioMat'X) and Faculty member in the PhD program (BioMedicine) at the Facultad de Medicina, Universidad de los Andes in Santiago de Chile. Haidar is an oral and maxillofacial surgeon with a PhD in biomaterials and tissue engineering from McGill University, Montréal , Canada; and post-doctoral training at the Montréal Shriners Hospital, McGill University Health Center, Montréal , Canada. Before moving to Chile, he served as the Chair of Excellence in BioEngineering at the Université de Limoges, Limoges, France and was an Assistant Professor at the Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT, USA. Haidar has won several prestigious awards from the International Bone and Mineral Society, Society for Biomaterials, Canadian Biomaterial Society and Canadian/Lebanese Society of Plastic Surgeons, to name a few. He has more than 80 publications, conference proceedings, text-books and patents and is an editorial board member of several national and international scientific journals and periodicals.

Patient-oriented application of bionanotechnology; Biopolymers; Bioceramics and Drug delivery systems for the repair; Restoration and replacement of challenging craniofacial and orthopaedic defects.

Hans Fecht is Chaired Professor in the Faculty of Engineering and Computer Science at the University of Ulm, Germany, and Director of the “Institute of Micro and Nano-materials". He received his PhD at the University of Saarbrücken in 1984 and became professor at the University of Augsburg after postdoctoral fellowships at the University of Wisconsin-Madison and the California Institute of Technology, USA. In 1993 he was appointed Full Professor at the Technical University Berlin and in 1997 at University of Ulm. He directs a group of about 30 academics, students, technicians and visitors. He has published more than 450 scientific papers, coordinated numerous national, European and international research projects and (co)organized a number of international workshops, symposia and conferences. Hans Fecht was awarded with the Leibniz Prize of the German Research Foundation (DFG), "Pioneer of Nanotechnology" (Deutsche Bank), the Innovation Award of the Association of German Engineers (VDI) and is member of the European Academy of Sciences and Arts. In addition, he is the office director of the EUREKA Cluster Metallurgy Europe.

Prof. Fecht directs a group of about 30 graduate students, PhD students and Post-Docs in the field. He has (co )authored more than 450 technical papers, (co-) organized several international conferences (micromaterials) and workshops (EPS, ESA, nanoDanube). He is a member of several international advisory boards and has a long standing history of managing national and international projects in the field of materials science and nanotechnology

Dr Liangchi Zhang is Scientia Professor at the University of New South Wales (UNSW Sydney), Australia; prior to which he has worked at the University of Cambridge UK, the National Mechanical Engineering Laboratory MITI Japan and the University of Sydney Australia. His research is on both the fundamentals and industrial applications in the cross- disciplinary field of precision manufacturing, nanotechnology and biomedical manufacturing. His research outcomes have been well received and have led to tremendous economic benefits for industry in tens of million dollars per annum. He was awarded a higher doctoral degree, Doctor of Engineering, at the University of Sydney in 2005 and elected Fellow of the Australian Academy of Technological Science and Engineering in 2006.

Nanotechnology, Precision manufacturing, Bio-manufacturing, Characterisation of advanced materials, Tribology, Solid mechanics, Computational mechanics

Prof. Magdy Y. Abdelaal was born in 1959 and obtained his PhD in 1991 from Mansoura University, Egypt in collaboration with FU-Berlin, Germany. He is a Professor of Polymer Chemistry at Mansoura University, Egypt. Meanwhile he was a Professor of Polymer Chemistry at KAU, Saudi Arabia on sabbatical between 2004 and 2016. He is the Head of the Organic Chemistry Division; Director of the "Research and Development of Plastic and Rubber Industry Unit", Mansoura University, 2016; and Steering Committee Member of the Support Center for Small and Medium Industries, Mansoura University. He was a visiting professor at KAUST-Cornell Center for Energy and Sustainability, Cornell University, NY, USA for two months in 2015. Besides, he has cross-cooperation with many institutions such as LNF/INFN, Italy; NIMC and Toyohashi University of Technology, Japan and most institutions in Egypt. He attended and co- organized many national and international conferences. He has published over 50 papers in reputed ISI recognized journals and served as a reviewer for many international journals. His research focuses on polymers and their nano-composites in wastewater treatment, energy and sustainability-related polymeric nanomaterials, polymer recycling, pharmaceutical and biomedical applications and as templates for photonanocatalysts preparation

Bio-polymers and drug delivery systems, Energy and sustainability-related polymeric nanomaterials, Polymeric nano-materials and nano-composite

Professor Puzyn is the author of over 70 scientific articles in leading journals (eg. Nature Nanotechnology). His work has been cited more than 1,000 times and the Hirsch index is 21. Professor Puzyn is an active member of the international emvironment involved in the issues of chemical safety and nanotechnology: as the leader of two international projects thanks to the EU 7th Framework Programme (NanoBRIDGES and NanoPUZZLES), initiatives under the European Nanosafety Cluster and as a member of the Steering Committee of the MODENA Action, implemented within the framework of COST - European Cooperation in Science and Technology. He is also the winner of many prestigious national and international awards, i.e.: individual scholarship of the Japanese Association for the Promotion of Science, grants of the Foundation for Polish Science (programmes: START, HOMING and FOCUS), a scholarship of the Ministry of Science and Higher Education holder and the winner of the Polish Prime Minister Prize for the best habilitation thesis in 2012.

Computational methods for designing nanomaterials

Mr. De la Parra-Solomon is an entrepreneur focused on Information Technology, Education and Health. He is creative, results-driven and has 16+ years of Digital Strategy experience in architecture and implementation. He serves as CEO and Co-founding Partner at The Solomon Brokerage Firm (www.solomonbrokerage.com). He also is the former Vice President of Digital Strategy at Mass Media Division, while also being the CEO of De la Parra Mobile Solutions. He is the former Vice President of Strategy and Operations PetroM Corp and its subdivision PetroM Logistics and PetroM Pharma, the former COO & Co-founder at RegenerAge Clinic & RegenerAge Beauty. Mr. De la Parra-Solomon is the former CEO & Founder at Astrum Salud Móvil and its Telemedicine service Astrum Móvil, former Digital Strategy Director & Co-founder at Dr. Jois, BiorganicAging, What Skin Needs/WSN International Pty. Ltd. He also served as a member of the Board of Advisors and is former Chief Marketing Officer at ReAnima Advanced Biosciences and served as Digital Media Director at Bioquark, Inc. He also served as the Latin America Region Manager and Digital Strategy adviser at CardiacSense and is former CITO & Senior Partner at Cerezo Editores.

Regenerative Medicine, Continued Medical Education Platforms, Biotechnology, Synthetic Biology, Reprogramming Medicine, Molecular Biology, Medical Technologies & Digital Health, Neuroscience, Artificial Intelligence Applications in Health